Skip to main content
Clinical Trials/IRCT20221011056144N1
IRCT20221011056144N1
Recruiting
Phase 2

Comparison of the effect of albumin administration on attenuation, lung involvement and blood oxygenation of patients with Covid-19 admitted to intensive care unit with albumin level less than 3 and 2 g dl ( Clinical Trial )

Karaj University of Medical Sciences0 sites52 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Karaj University of Medical Sciences
Enrollment
52
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Karaj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 18 years and above
  • PCR test positive
  • Observation of lung involvement in CT scan
  • Hypoxia (arterial oxygen saturation less than 90%)
  • Patients with consent to participate in the study

Exclusion Criteria

  • Hypoxia (arterial oxygen saturation more than 90%)

Outcomes

Primary Outcomes

Not specified

Similar Trials